Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Amylx Pharmaceuticals Inc (AMLX) – Amylx Pharmaceuticals Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Amylyx Pharmaceuticals (AMLX) trades at $15.05, down 0.92% on the day, amidst a pivotal year for its lead drug candidate, avexitide. The stock shows a bullish technical signal from moving averages, with key support at $14 and resistance at $16. Fundamentally, the company is in a pre-revenue investment phase, reporting significant net losses and negative cash flow from operations as it funds clinical trials. Analyst sentiment is overwhelmingly positive, with a consensus price target of $28.33, driven by anticipation of Phase 3 trial results expected in Q3 2026.
The investment case hinges on the successful development and commercialization of avexitide for post-bariatric hypoglycemia. The primary opportunity is the substantial upside to the analyst price target, reflecting confidence in the drug's potential. Key risks include clinical trial failure, cash burn necessitating further financing, and the stock's high price-to-book valuation despite negative profitability metrics. Near-term catalysts are the Phase 3 data readout and subsequent regulatory and launch plans for 2027.
Read full analysis

Key Stats

  • Market Cap
    $1.70B
  • Sector
    Health
  • 3M Drawdown
    -30.61%
  • Enterprise Value
    $1.42B
  • Dividend Yield
    -
  • Trading Activity
    22% Buy | 78% Sell
  • Typical Hold Time
    10 days
$15.6
52W Low: $5.02
23 Jun 2025
52W High: $18.36
17 Apr 2026

Amylx Pharmaceuticals Inc (AMLX) is currently valued at a market capitalization of $1.70B, with an enterprise value of $1.42B. Over the past 52 weeks, Amylx Pharmaceuticals Inc has traded between a low of $5.02 and a high of $18.36, highlighting its annual price range. Over the past three months, Amylx Pharmaceuticals Inc has recorded a drawdown of -30.61%, reflecting recent price volatility. On average, investors hold Amylx Pharmaceuticals Inc for approximately 10 days, indicating typical investor behavior on the platform.

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.


People also bought


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $1.70B
  • Sector
    Health
  • 3M Drawdown
    -30.61%
  • Enterprise Value
    $1.42B
  • Dividend Yield
    -
  • Trading Activity
    22% Buy | 78% Sell
  • Typical Hold Time
    10 days
$15.6
52W Low: $5.02
23 Jun 2025
52W High: $18.36
17 Apr 2026

Amylx Pharmaceuticals Inc (AMLX) is currently valued at a market capitalization of $1.70B, with an enterprise value of $1.42B. Over the past 52 weeks, Amylx Pharmaceuticals Inc has traded between a low of $5.02 and a high of $18.36, highlighting its annual price range. Over the past three months, Amylx Pharmaceuticals Inc has recorded a drawdown of -30.61%, reflecting recent price volatility. On average, investors hold Amylx Pharmaceuticals Inc for approximately 10 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!